Pfizer says COVID-19 vaccine will cost $110-$130 per dose

Pfizer said the commercial pricing for adult COVID-19 vaccine doses could start in early 2023, depending on when the U.S. government phases out its program of buying the shots.

VIDEO: Newport Beach doctor removes 23 contact lenses from woman's eye

A Newport Beach doctor has shared a now-viral video of her removing nearly two dozen contact lenses from the eye of an elderly patient.

Cheaper, over-the-counter hearing aids now available in US stores

Several U.S. retailers are now selling over-the-counter hearing aids at a cheaper cost compared to prescription devices, officials say. Here’s where to buy them.

FDA confirms widespread shortage of Adderall in the US

The largest U.S. manufacturer Adderall, a prescription drug used primarily to treat ADHD, has been experiencing “ongoing intermittent manufacturing delays,” the FDA said.

How death doulas help people and families with the dying process

Just as a birth doula helps bring a new life into the world, a death doula helps patients and families as they prepare for the end.

CDC says universal masking no longer recommended inside some hospitals, nursing homes

The CDC has eased its universal masking recommendations for some health care facilities — unless they’re located in areas of high COVID-19 transmission.

Spike in respiratory illnesses sending kids to hospitals

With everyone back to school, more people heading back to the office, and COVID protocols being lifted, it seems like more people, especially kids, are getting sick.

Health panel calls for anxiety screenings for all adults under 65

A panel of medical experts is saying all American adults under the age of 65 should get regular screenings for anxiety, just like high blood pressure and heart disease.

Virtual hospital visits are the 'now of medicine'

Video consultations connect patients with medical specialists as a way to quickly receive care. This technological protocol isn't the "future of medicine" — it is here right now.

FDA OKs Daxxify, an anti-wrinkle injection and Botox competitor

Studies showed the Daxxify drug can temporarily improve moderate to severe frown lines in adults for a median duration of about six months, according to the company.